Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies

por Yong, K, Cavet, J, Johnson, P, Morgan, G, Williams, C, Nakashima, D, Akinaga, S, Oakervee, H, Cavenagh, J
Publicado 2016